B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Vip

A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.

299 PubMed studies analyzed · 2 RCTs · Evidence Score: 44.1

Research Domains

Vip has been studied across 24 research domains including 🦠 Gut & Microbiome, 🛡️ Immunity, 🔬 Oncology, 🔬 Inflammation, 🫁 Respiratory. The primary research focus is 🦠 Gut & Microbiome with 99% of studies addressing this area.

Loading evidence profile...

This evidence profile for Vip is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.